Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Ongoing Research Protocols for the Pharmacological Treatment of Neuropsychiatric Symptoms in Dementia. Local targets link to admitted publications; unresolved targets remain external evidence.
Neuropsychiatric symptoms in Alzheimer's disease
10.1016/j.jalz.2011.05.2410 · 2011 · External reference
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
10.1016/j.jalz.2011.03.005 · 2011 · External reference
Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer's Disease
10.3389/fphar.2019.01062 · 2019 · External reference
Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: The Cache County Dementia Progression Study
10.1176/appi.ajp.2014.14040480 · 2015 · External reference
Delusions and hallucinations are associated with worse outcome in Alzheimer disease
10.1001/archneur.62.10.1601 · 2005 · External reference
Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease
2006 · External reference
Neuropsychiatric symptoms in dementia may predict caregiver burden: a Sicilian exploratory study
10.1111/psyg.12197 · 2017 · External reference
Spousal Caregiving Is Associated with an Increased Risk of Frailty: A Case-Control Study
2018 · External reference
The contribution of neuropsychiatric symptoms to the cost of dementia care
10.1002/gps.1594 · 2006 · External reference
Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population
10.1016/j.trci.2019.01.002 · 2019 · External reference
Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) in Long-term Care Centers in Québec, Canada: A Strategy for Best Practices
10.1016/j.jamda.2019.08.027 · 2020 · External reference
Exploring Antipsychotic Prescribing Behaviors for Nursing Home Residents With Dementia: A Qualitative Study
10.1016/j.jamda.2018.07.004 · 2018 · External reference
Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel
10.1111/jgs.12730 · 2014 · External reference
Nonpharmacologic management of behavioral symptoms in dementia
10.1001/jama.2012.36918 · 2012 · External reference
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
10.1007/s40268-019-0272-1 · 2019 · External reference
What is the impact of using outdoor spaces such as gardens on the physical and mental well-being of those with dementia? A systematic review of quantitative and qualitative evidence
10.1016/j.jamda.2014.05.013 · 2014 · External reference
Assessment and management of behavioral and psychological symptoms of dementia
10.1136/bmj.h369 · 2015 · External reference
Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study
10.1016/j.jamda.2014.07.012 · 2014 · External reference
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm
10.1001/jamapsychiatry.2014.3018 · 2015 · External reference
Precipitants of Delirium in Older Inpatients Admitted in Surgery for Post-Fall Hip Fracture: An Observational Study
2018 · External reference
Research priorities to reduce the global burden of dementia by 2025
10.1016/s1474-4422(16)30235-6 · 2016 · External reference
Dementia priority setting partnership with the James Lind Alliance: using patient and public involvement and the evidence base to inform the research agenda
10.1093/ageing/afv143 · 2015 · External reference
Need to Recalibrate Research Outcomes in Alzheimer's Disease: Focus on Neuropsychiatric Symptoms
10.1111/jgs.14989 · 2017 · External reference
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
10.1016/j.trci.2017.07.001 · 2017 · External reference
Alzheimer's disease drug development pipeline: 2019
10.1016/j.trci.2019.05.008 · 2019 · External reference
A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer's Disease
2018 · External reference
Medication Development for Agitation and Aggression in Alzheimer Disease: Review and Discussion of Recent Randomized Clinical Trial Design
2014 · External reference
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients
1997 · External reference
A description of agitation in a nursing home
10.1093/geronj/44.3.m77 · 1989 · External reference
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
10.1017/s1041610214001963 · 2015 · External reference
Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study
10.1002/gps.4933 · 2018 · External reference
Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale
10.1016/j.jamda.2018.07.005 · 2018 · External reference
Reasoning about frailty in neurology: neurobiological correlates and clinical perspectives
2014 · External reference
Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory
10.1002/gps.3904 · 2013 · External reference
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease
10.1097/jgp.0b013e3181d6b68d · 2010 · External reference
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial
10.1001/jama.2015.10214 · 2015 · External reference
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
10.1016/j.jagp.2019.05.002 · 2019 · External reference
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial
10.1017/s1041610215001106 · 2015 · External reference
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
10.1056/nejmoa061240 · 2006 · External reference
A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment
10.3233/jad-171161 · 2018 · External reference
Unresolved reference
External reference
